INS and type 2 diabetes mellitus: For example, in Zuckerfatty rats, a standard rodent model of T2DM, INT131 was more potent thanrosiglitazone in reducing serum glucose(Figure 6), insulin, triglyceride, andNEFA concentrations and in improving glucose tolerance [17].